355 related articles for article (PubMed ID: 12715437)
1. [Significance of alloantibodies other than anti-D hemolytic disease of the fetus and newborn (HDF/N)].
Lenkiewicz B; Zupańska B
Ginekol Pol; 2003 Jan; 74(1):48-54. PubMed ID: 12715437
[TBL] [Abstract][Full Text] [Related]
2. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
[TBL] [Abstract][Full Text] [Related]
3. [Hemolytic disease of the newborn and irregular blood group antibodies in the Netherlands: prevalence and morbidity].
van Dijk BA; Hirasing RA; Overbeeke MA
Ned Tijdschr Geneeskd; 1999 Jul; 143(28):1465-9. PubMed ID: 10443262
[TBL] [Abstract][Full Text] [Related]
4. Twin pregnancy complicated by severe hemolytic disease of the fetus and newborn due to anti-g and anti-C.
Trevett TN; Moise KJ
Obstet Gynecol; 2005 Nov; 106(5 Pt 2):1178-80. PubMed ID: 16260562
[TBL] [Abstract][Full Text] [Related]
5. Hemolytic disease of the newborn due to combination of anti-E and anti-S in the first pregnancy.
Kanra T; Tunçer M; Pirnar A
Turk J Pediatr; 1983; 25(1):49-54. PubMed ID: 6417855
[No Abstract] [Full Text] [Related]
6. High anti-HLA response in women exposed to intrauterine transfusions for severe alloimmune hemolytic disease is associated with mother-child HLA triplet mismatches, high anti-D titer, and new red blood cell antibody formation.
Verduin EP; Schonewille H; Brand A; Haasnoot GW; Claas FH; Lindenburg IT; Lopriore E; Oepkes D; Roelen DL; Doxiadis II
Transfusion; 2013 May; 53(5):939-47. PubMed ID: 22924899
[TBL] [Abstract][Full Text] [Related]
7. [Foetomaternal erythrocyte incompatibilities: from immunohaematologic surveillance of pregnant women to haemolytic disease of the newborn].
Miquel E; Cavelier B; Bonneau JC; Rouger P
Transfus Clin Biol; 2005 Feb; 12(1):45-55. PubMed ID: 15814293
[TBL] [Abstract][Full Text] [Related]
8. Laboratory assays for predicting the severity of haemolytic disease of the fetus and newborn.
Hadley AG
Transpl Immunol; 2002 Aug; 10(2-3):191-8. PubMed ID: 12216949
[TBL] [Abstract][Full Text] [Related]
9. Neonatal and Obstetrical Outcomes of Pregnancies Complicated by Alloimmunization.
Bahr TM; Tweddell SM; Zalla JM; Dizon-Townson D; Ohls RK; Henry E; Ilstrup SJ; Kelley WE; Ling CY; Lindgren PC; O'Brien EA; Christensen RD
Pediatrics; 2024 Jun; 153(6):. PubMed ID: 38784990
[TBL] [Abstract][Full Text] [Related]
10. Maternal ABO-mismatched blood for intrauterine transfusion of severe hemolytic disease of the newborn due to anti-Rh17.
Denomme GA; Ryan G; Seaward PG; Kelly EN; Fernandes BJ
Transfusion; 2004 Sep; 44(9):1357-60. PubMed ID: 15318861
[TBL] [Abstract][Full Text] [Related]
11. Early plasmapheresis followed by high-dose γ-globulin treatment saved a severely Rho-incompatible pregnancy.
Isojima S; Hisano M; Suzuki T; Sago H; Murashima A; Yamaguchi K
J Clin Apher; 2011; 26(4):216-8. PubMed ID: 21506141
[TBL] [Abstract][Full Text] [Related]
12. [Detection and analysis of anti-Rh blood group antibodies].
Wu YJ; Wu Y; Chen BC; Liu Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Jun; 24(6):604-6. PubMed ID: 18538092
[TBL] [Abstract][Full Text] [Related]
13. [Hemolytic disease of the newborn caused by rarely occurring antibodies to various blood group systems].
Maszkiewicz W; Ornat K; Zarczyńska B; Bagińska T; Irzyńska D
Acta Haematol Pol; 1988; 19(1-2):77-80. PubMed ID: 3149115
[No Abstract] [Full Text] [Related]
14. [Anti-K antibodies in pregnant women and genotyping of K antigen in foetuses].
Zupańska B; Nowaczek-Migas M; Michalewska B; Wielgoś M; Orzińska A
Ginekol Pol; 2008 Jun; 79(6):410-4. PubMed ID: 18652128
[TBL] [Abstract][Full Text] [Related]
15. Hemolytic disease of the newborn due to rare alloantibodies.
Zuliani G; Moroni GA; Buscaglia M; Morotti R; Pardi G
Ric Clin Lab; 1983; 13(4):449-57. PubMed ID: 6419339
[TBL] [Abstract][Full Text] [Related]
16. Fetal hemolytic disease due to anti-Rh17 alloimmunization.
Hirose M; Nakanishi K; Kaku S; Moro H; Hodohara K; Aotani H; Takebayashi K; Noda Y
Fetal Diagn Ther; 2004; 19(2):182-6. PubMed ID: 14764967
[TBL] [Abstract][Full Text] [Related]
17. Severe hemolytic disease of fetus and newborn caused by red blood cell antibodies undetected at first-trimester screening (CME).
Dajak S; Stefanović V; Capkun V
Transfusion; 2011 Jul; 51(7):1380-8. PubMed ID: 21214583
[TBL] [Abstract][Full Text] [Related]
18. [Management of feto-maternal red cell allo-immunizations].
Bricca P; Guinchard E; Guitton Bliem C
Transfus Clin Biol; 2011 Apr; 18(2):269-76. PubMed ID: 21397546
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of erythroid progenitor cells by anti-Kell antibodies in fetal alloimmune anemia.
Vaughan JI; Manning M; Warwick RM; Letsky EA; Murray NA; Roberts IA
N Engl J Med; 1998 Mar; 338(12):798-803. PubMed ID: 9504940
[TBL] [Abstract][Full Text] [Related]
20. Hemolytic disease of newborn due to anti-Jk b in a woman with high risk pregnancy.
Thakral B; Malhotra S; Saluja K; Kumar P; Marwaha N
Transfus Apher Sci; 2010 Aug; 43(1):41-3. PubMed ID: 20558106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
